MIST Earnings Date: Nov 11, 2026 (Estimated) — Milestone Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is MIST's next earnings date?
Milestone Pharmaceuticals Inc. (MIST) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20 on revenue of $1.0M.
How did MIST do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Milestone Pharmaceuticals Inc. posted EPS of -$0.21 versus the -$0.20 estimate, a miss of 10.5%. Revenue was $559,000 against a $816,667 estimate. The stock's 1-day post-earnings move was -11.4%.
How much does MIST stock move after earnings?
MIST beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.4% (up or down) in the day after earnings.
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.20 | -0.21 | -10.53% | $559,000 | ❌ Miss | -11.42% | -15.75% | -17.32% |
| 2026-05-13 | Q1 2026 | 0.14 | -0.20 | -242.86% | $238,000 | ❌ Miss | -9.47% | -24.74% | -33.16% |
| 2026-03-20 | Q4 2025 | -0.18 | -0.16 | +11.11% | $1.5M | ✅ Beat | -20.00% | -32.35% | +20.00% |
| 2025-11-12 | Q3 2025 | -0.17 | -0.12 | +29.41% | $0 | ✅ Beat | +1.05% | +26.18% | +54.45% |
| 2025-08-12 | Q2 2025 | -0.18 | -0.20 | -11.11% | $0 | ❌ Miss | +7.10% | +9.68% | +10.32% |
| 2025-05-14 | Q1 2025 | -0.19 | -0.31 | -63.16% | $0 | ❌ Miss | -1.68% | +16.81% | +41.18% |
| 2025-03-13 | Q4 2024 | -0.15 | -0.19 | -26.67% | $0 | ❌ Miss | +5.18% | +3.11% | -61.14% |
| 2024-11-12 | Q3 2024 | -0.16 | -0.14 | +12.50% | $0 | ✅ Beat | -3.61% | -12.37% | -3.09% |
Showing last 8 quarters.